West Pharmaceutical Services financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$541.60M $699.70M $913.30M $1.02B $1.05B $1.06B $1.10B $1.19B $1.27B $1.37B $1.42B $1.40B $1.51B $1.60B $1.72B $1.84B $2.15B $2.83B $2.89B $2.95B $0.00M
GM % Gross Margin %
29.01% 28.08% 28.99% 28.61% 28.79% 28.76% 28.80% 28.46% 30.61% 31.77% 31.50% 32.56% 33.23% 32.07% 31.76% 32.92% 35.76% 41.59% 39.36% 38.31% 0.00%
OM Operating Margin
9.88% 10.50% 11.57% 11.08% 11.85% 10.23% 9.64% 9.99% 11.28% 11.97% 12.90% 9.29% 15.17% 14.96% 14.61% 16.09% 19.57% 27.08% 26.46% 24.09% 0.00%
EPS Earnings Per Share
$0.72 $1.00 $1.19 $1.19 $1.06 $1.05 $1.17 $1.38 $1.63 $1.78 $1.83 $2.18 $2.78 $2.81 $3.24 $4.76 $8.58 $8.58 $8.08 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.27 $0.29 $0.31 $0.33 $0.35 $0.00 $0.39 $0.41 $0.45 $0.49 $0.53 $0.57 $0.61 $0.66 $0.69 $0.74 $0.78 $0.00
PR % Payout Ratio %
0 0 0 22.69% 24.37% 29.25% 31.43% 29.91% 0 23.93% 23.03% 24.59% 22.48% 19.06% 20.28% 18.83% 13.87% 8.04% 8.62% 9.65% 0
Sha. Shares
61.22m 63.44m 65.31m 64.73m 65.43m 66m 66.6m 67.43m 68.25m 69.84m 71.07m 72.09m 73.18m 74.25m 74.08m 73.99m 73.93m 73.82m 74.03m 0m 72.84m
OCF Operating Cash Flow
$69.10M $79.80M $143.80M $129.20M $135.00M $137.70M $138.30M $130.70M $187.40M $220.50M $182.90M $212.40M $219.40M $263.30M $288.60M $367.20M $472.50M $584.00M $724.00M $776.50M $0.00M
FCF Free Cash Flow
$11.70M $25.70M $53.50M $-0.20M $-3.60M $32.80M $67.20M $35.30M $56.10M $68.60M $71.00M $80.80M $49.20M $132.50M $183.90M $240.80M $298.10M $330.60M $439.40M $358.30M $0.00M
FCFS Free Cash Flow Per Share
$0.20 $0.41 $0.83 $-0.07 $-0.06 $0.46 $0.97 $0.50 $0.81 $0.93 $1.00 $1.12 $0.67 $1.79 $2.49 $3.25 $4.03 $4.44 $5.91 $5.58 $0.00